Aehr Test Systems vs Advanced Micro Fabrication: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Aehr Test Systems (AEHR)

Q3 202617 Jun – 17 Jul 2026

▲3

Aehr's AI pivot drives record bookings and a bold 2027 revenue forecast

Record bookings and AI-driven revenue forecast Aehr reported record quarterly bookings of $60.7 million and guided fiscal 2027 revenue to $130–150 million, nearly triple last year's $50 million. Management says AI processors and silicon photonics are now the main growth drivers, with 71% of revenue from AI-related chips. This directly boosts investor expectations for future sales and profits.
This is the core new event that explains the stock's surge and future growth outlook.
Earnings beat and return to profitability expected Aehr beat earnings estimates with non-GAAP EPS of $0.11 and revenue up 33% year-over-year to $18.8 million. Management expects non-GAAP net income to be 18–22% of revenue in fiscal 2027, signaling a return to profitability. This reassures investors that the company can convert strong demand into actual profits.
It shows the financial health behind the stock move and supports the bullish case.
Successful pivot from EV chips to AI processors Aehr has shifted from relying on electric-vehicle silicon carbide chips to AI accelerators, CPUs, and network processors. Two years ago, over 95% of business was EV-related; now AI chips make up 71% of revenue. This diversification reduces dependence on a single market and taps into the massive AI infrastructure buildout.
It explains the strategic transformation that is driving new orders and investor enthusiasm.
Valuation concerns and analyst caution Despite the strong news, Wall Street sees AEHR as overvalued. The consensus rating is Moderate Buy with a mean price target near $64, implying potential downside of over 40% from recent levels. The stock trades at 81 times trailing sales, so any disappointment could lead to a sharp pullback.
It provides a fair counterweight to the bullish drivers and highlights the risk for new investors.

July 202617 Jun – 17 Jul 2026

▲3

Aehr's AI pivot drives record bookings and a bold 2027 revenue forecast

Record bookings and AI-driven revenue forecast Aehr reported record quarterly bookings of $60.7 million and guided fiscal 2027 revenue to $130–150 million, nearly triple last year's $50 million. Management says AI processors and silicon photonics are now the main growth drivers, with 71% of revenue from AI-related chips. This directly boosts investor expectations for future sales and profits.
This is the core new event that explains the stock's surge and future growth outlook.
Earnings beat and return to profitability expected Aehr beat earnings estimates with non-GAAP EPS of $0.11 and revenue up 33% year-over-year to $18.8 million. Management expects non-GAAP net income to be 18–22% of revenue in fiscal 2027, signaling a return to profitability. This reassures investors that the company can convert strong demand into actual profits.
It shows the financial health behind the stock move and supports the bullish case.
Successful pivot from EV chips to AI processors Aehr has shifted from relying on electric-vehicle silicon carbide chips to AI accelerators, CPUs, and network processors. Two years ago, over 95% of business was EV-related; now AI chips make up 71% of revenue. This diversification reduces dependence on a single market and taps into the massive AI infrastructure buildout.
It explains the strategic transformation that is driving new orders and investor enthusiasm.
Valuation concerns and analyst caution Despite the strong news, Wall Street sees AEHR as overvalued. The consensus rating is Moderate Buy with a mean price target near $64, implying potential downside of over 40% from recent levels. The stock trades at 81 times trailing sales, so any disappointment could lead to a sharp pullback.
It provides a fair counterweight to the bullish drivers and highlights the risk for new investors.

Latest17 Jun – 17 Jul 2026

▲3

Aehr's AI pivot drives record bookings and a bold 2027 revenue forecast

Record bookings and AI-driven revenue forecast Aehr reported record quarterly bookings of $60.7 million and guided fiscal 2027 revenue to $130–150 million, nearly triple last year's $50 million. Management says AI processors and silicon photonics are now the main growth drivers, with 71% of revenue from AI-related chips. This directly boosts investor expectations for future sales and profits.
This is the core new event that explains the stock's surge and future growth outlook.
Earnings beat and return to profitability expected Aehr beat earnings estimates with non-GAAP EPS of $0.11 and revenue up 33% year-over-year to $18.8 million. Management expects non-GAAP net income to be 18–22% of revenue in fiscal 2027, signaling a return to profitability. This reassures investors that the company can convert strong demand into actual profits.
It shows the financial health behind the stock move and supports the bullish case.
Successful pivot from EV chips to AI processors Aehr has shifted from relying on electric-vehicle silicon carbide chips to AI accelerators, CPUs, and network processors. Two years ago, over 95% of business was EV-related; now AI chips make up 71% of revenue. This diversification reduces dependence on a single market and taps into the massive AI infrastructure buildout.
It explains the strategic transformation that is driving new orders and investor enthusiasm.
Valuation concerns and analyst caution Despite the strong news, Wall Street sees AEHR as overvalued. The consensus rating is Moderate Buy with a mean price target near $64, implying potential downside of over 40% from recent levels. The stock trades at 81 times trailing sales, so any disappointment could lead to a sharp pullback.
It provides a fair counterweight to the bullish drivers and highlights the risk for new investors.

Advanced Micro Fabrication Inc (688012.CG)

Q3 202624 Jul – 5 Aug 2026

▲4

AMEC Profit Surges, Samsung/SK Hynix Test Equipment, CXMT Stake Gains

First-half profit jumps 282-311% on strong demand AMEC expects first-half net profit up 282-311% year-on-year, with revenue up 34.89% to 6.69 billion yuan. The company also plans a 3.5 billion yuan expansion of its Lingang base. This shows booming demand for its chipmaking tools and supports a higher stock price.
Directly answers why the stock is moving: strong earnings growth and capacity expansion signal robust business momentum.
Samsung and SK Hynix test AMEC equipment for China plants Samsung and SK Hynix have been testing AMEC's etching equipment for about two years, aiming to use it at their Chinese plants to avoid US export restrictions. Although Samsung denied the report, the potential endorsement from global chip giants could open a large new market for AMEC.
This is a major new demand driver that could significantly expand AMEC's customer base and revenue.
CXMT strategic placement yields paper profit AMEC participated in the strategic placement of CXMT, a domestic DRAM leader, and its stake generated a paper profit of about 736 million yuan on the first trading day. This reflects AMEC's strategic positioning in the chip supply chain and adds to its investment gains.
Shows a direct financial benefit and strategic alignment that can boost investor sentiment.
New regulations protect IC layout designs China published revised regulations for protecting integrated circuit layout designs, effective October 2026. This supports the industry's shift to high-quality development and could benefit domestic equipment makers like AMEC by fostering a more innovative and protected environment.
Regulatory support for the semiconductor industry can improve the long-term outlook for AMEC.

July 202624 Jul – 5 Aug 2026

▲4

AMEC Profit Surges, Samsung/SK Hynix Test Equipment, CXMT Stake Gains

First-half profit jumps 282-311% on strong demand AMEC expects first-half net profit up 282-311% year-on-year, with revenue up 34.89% to 6.69 billion yuan. The company also plans a 3.5 billion yuan expansion of its Lingang base. This shows booming demand for its chipmaking tools and supports a higher stock price.
Directly answers why the stock is moving: strong earnings growth and capacity expansion signal robust business momentum.
Samsung and SK Hynix test AMEC equipment for China plants Samsung and SK Hynix have been testing AMEC's etching equipment for about two years, aiming to use it at their Chinese plants to avoid US export restrictions. Although Samsung denied the report, the potential endorsement from global chip giants could open a large new market for AMEC.
This is a major new demand driver that could significantly expand AMEC's customer base and revenue.
CXMT strategic placement yields paper profit AMEC participated in the strategic placement of CXMT, a domestic DRAM leader, and its stake generated a paper profit of about 736 million yuan on the first trading day. This reflects AMEC's strategic positioning in the chip supply chain and adds to its investment gains.
Shows a direct financial benefit and strategic alignment that can boost investor sentiment.
New regulations protect IC layout designs China published revised regulations for protecting integrated circuit layout designs, effective October 2026. This supports the industry's shift to high-quality development and could benefit domestic equipment makers like AMEC by fostering a more innovative and protected environment.
Regulatory support for the semiconductor industry can improve the long-term outlook for AMEC.

Latest24 Jul – 5 Aug 2026

▲4

AMEC Profit Surges, Samsung/SK Hynix Test Equipment, CXMT Stake Gains

First-half profit jumps 282-311% on strong demand AMEC expects first-half net profit up 282-311% year-on-year, with revenue up 34.89% to 6.69 billion yuan. The company also plans a 3.5 billion yuan expansion of its Lingang base. This shows booming demand for its chipmaking tools and supports a higher stock price.
Directly answers why the stock is moving: strong earnings growth and capacity expansion signal robust business momentum.
Samsung and SK Hynix test AMEC equipment for China plants Samsung and SK Hynix have been testing AMEC's etching equipment for about two years, aiming to use it at their Chinese plants to avoid US export restrictions. Although Samsung denied the report, the potential endorsement from global chip giants could open a large new market for AMEC.
This is a major new demand driver that could significantly expand AMEC's customer base and revenue.
CXMT strategic placement yields paper profit AMEC participated in the strategic placement of CXMT, a domestic DRAM leader, and its stake generated a paper profit of about 736 million yuan on the first trading day. This reflects AMEC's strategic positioning in the chip supply chain and adds to its investment gains.
Shows a direct financial benefit and strategic alignment that can boost investor sentiment.
New regulations protect IC layout designs China published revised regulations for protecting integrated circuit layout designs, effective October 2026. This supports the industry's shift to high-quality development and could benefit domestic equipment makers like AMEC by fostering a more innovative and protected environment.
Regulatory support for the semiconductor industry can improve the long-term outlook for AMEC.